Trisomy 21 Model Atlas
21 三体模型图谱
基本信息
- 批准号:10769002
- 负责人:
- 金额:$ 73.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAlzheimer&aposs DiseaseArchitectureAtlasesAutoimmune DiseasesBiological ModelsBloodBone MarrowBrainCellsChromosome 21Chromosome abnormalityClinicalCodeCommunitiesComplexCongenital Heart DefectsDataData SetDefectDevelopmentDown SyndromeEmbryoEnsureEtiologyFunctional disorderFunding OpportunitiesGene DosageGene ExpressionGenesGenetic DiseasesGrantHeartHematoxylin and Eosin Staining MethodHeterogeneityHumanHuman ChromosomesImageImmune systemImmunofluorescence ImmunologicIndividualIntellectual functioning disabilityIntestinesKidneyKnowledgeLinkLiverLungMediatingMetadataModelingMusMuscleNewborn InfantOrganOrganoidsPathologyPersonsPhenotypePopulationProtocols documentationResearchResearch PersonnelResourcesRespiratory Tract InfectionsSamplingSkin TissueStainsSystemTimeTissue atlasTissue-Specific Gene ExpressionTissuesTrisomyValidationWorkbody systemcell typedata hubdifferentiation protocolgenome-widehuman dataimprovedinduced pluripotent stem cellinsightmouse modelopen dataorgan growthprogramsrepositoryresponsesingle-cell RNA sequencingstem cell differentiationtranscriptometranscriptome sequencing
项目摘要
PROJECT SUMMARY.
Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), is the most prevalent chromosomal
abnormality and a leading cause of intellectual and developmental disability. T21 affects the development and/or
function of nearly every organ system, predisposing individuals with DS to many co-occurring conditions such
as Alzheimer’s disease, congenital heart defects, and autoimmune disorders, among others. Although it is
accepted that T21 causes genome-wide dysregulation of gene expression programs, little is known about how
T21 affects gene expression across different tissues and organs, and how these effects contribute to the etiology
of the co-occurring conditions of DS. Therefore, there is a clear need to understand the complex cause-effect
relationships between T21, altered gene expression, and organ development and pathophysiology.
Several mouse models of DS recapitulate key phenotypes of DS and have been used to study gene expression
dysregulation in DS. Additionally, induced pluripotent stem cell (iPSC) systems have been employed to study the
effects of T21 in human cell types. Therefore, in clear response to the Funding Opportunity Announcement PAR-
22-247, we propose here to generate a Trisomy 21 Model Atlas of tissue-specific murine and human
transcriptomes, matched to detailed metrics of organ development and architecture. The use of mouse
models will provide insights into tissue- and developmental stage-specific transcriptome changes and
pathophysiology, while human cell types differentiated from iPSCs will dissect cell-intrinsic features of T21 and
validate findings from the mouse models. Our Specific Aims are:
1. Generate an atlas of gene expression programs affected by trisomy 21 across model systems.
Supported by strong preliminary data, we propose here to complete an atlas of transcriptome changes in ten
organs across three developmental stages in mice and matched data from human cell types derived from iPSCs.
2. Define the impact of trisomy 21 on organ development and pathophysiology at the cellular level. To
investigate the link between dysregulated gene expression and tissue dysfunction, we will assess organ
development and pathophysiology through histopathological profiling, multiplexed immunofluorescence imaging,
single-cell RNA-sequencing, and characterization of human organoids derived from iPSCs.
3. Curate, organize, and share all data for open access through the INCLUDE Data Hub. We will ensure
that all data is made publicly available in the INCLUDE Data Hub by completing careful file curation and
organization, developing a metadata schema, and creating a code repository. This will ensure that the atlas
becomes a lasting resource that can be used beyond the scope of this grant.
Altogether, this resource will advance our understanding of the effects of T21 on organ development and
pathology, while enabling findings cross-validated in mouse models and human cell types.
项目总结。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joaquin M. Espinosa其他文献
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitis
- DOI:
10.1016/j.jaci.2024.07.030 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Sinéad Ryan;Louise Crowe;Sofía N. Almeida Cruz;Matthew D. Galbraith;Carol O’Brien;Juliet A. Hammer;Ronan Bergin;Shauna K. Kellett;Gary E. Markey;Taylor M. Benson;Olga Fagan;Joaquin M. Espinosa;Niall Conlon;Claire L. Donohoe;Susan McKiernan;Andrew E. Hogan;Eóin N. McNamee;Glenn T. Furuta;Calies Menard-Katcher;Joanne C. Masterson - 通讯作者:
Joanne C. Masterson
Sa1249: ASSESSMENT OF A GENETIC RISK SCORE FOR CELIAC DISEASE IN DOWN SYNDROME
- DOI:
10.1016/s0016-5085(22)60849-7 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Marisa G. Stahl;Jessica R. Shaw;Angela L. Rachubinski;Matthew D. Galbraith;Paul Norman;Sameer Chavan;Laura A. Leaton;Ronald J. Sokol;Edwin Liu;Joaquin M. Espinosa - 通讯作者:
Joaquin M. Espinosa
Joaquin M. Espinosa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joaquin M. Espinosa', 18)}}的其他基金
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
唐氏综合症回归障碍治疗的机制研究
- 批准号:
10701872 - 财政年份:2022
- 资助金额:
$ 73.68万 - 项目类别:
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
唐氏综合症回归障碍治疗的机制研究
- 批准号:
10519053 - 财政年份:2022
- 资助金额:
$ 73.68万 - 项目类别:
A Pilot for Enhancing Support for a Federated Framework of Biospecimens for Down Syndrome Research via the INCLUDE Data Hub
通过 INCLUDE 数据中心加强对唐氏综合症研究生物样本联合框架的支持的试点
- 批准号:
10671310 - 财政年份:2020
- 资助金额:
$ 73.68万 - 项目类别:
Interferon hyperactivity, COVID19, and Down syndrome
干扰素过度活跃、新冠肺炎 (COVID19) 和唐氏综合症
- 批准号:
10215951 - 财政年份:2020
- 资助金额:
$ 73.68万 - 项目类别:
Understanding Down Syndrome as an Interferonopathy
将唐氏综合症理解为一种干扰素病
- 批准号:
9892863 - 财政年份:2019
- 资助金额:
$ 73.68万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)